Table 5.
Negative Predictive Value | Positive Predictive Value | |||
---|---|---|---|---|
Model | 17% prevalence | 32% prevalence | 17% prevalence | 32% prevalence |
Baseline (age + sex + APOE) | 0.913 (0.883, 0.944) | 0.820 (0.764, 0.878) | 0.274 (0.232, 0.324) | 0.455 (0.391, 0.535) |
PRS | 0.919 (0.889, 0.949) | 0.831 (0.773, 0.894) | 0.286 (0.241, 0.337) | 0.471 (0.402, 0.550) |
XGBoost | 0.950 (0.925, 0.975) | 0.893 (0.840, 0.946) | 0.341 (0.290, 0.402) | 0.524 (0.456, 0.608) |
NODEnn | 0.937 (0.902, 0.969) | 0.866 (0.802, 0.929) | 0.188 (0.159, 0.222) | 0.319 (0.278, 0.370) |
PRS + XBGoost | 0.933 (0.905, 0.960) | 0.861 (0.808, 0.915) | 0.354 (0.301, 0.415) | 0.550 (0.479, 0.641) |
XGBoost + NODEnn | 0.951 (0.924, 0.975) | 0.892 (0.840, 0.945) | 0.347 (0.296, 0.405) | 0.532 (0.462, 0.616) |
PRS + NODEnn | 0.935 (0.905, 0.964) | 0.863 (0.803, 0.920) | 0.263 (0.225, 0.312) | 0.427 (0.370, 0.493) |
PRS + XGBoost + NODEnn | 0.935 (0.907, 0.961) | 0.864 (0.810, 0.917) | 0.383 (0.325, 0.452) | 0.593 (0.511, 0.690) |